Hi Cal

Quick links to important sections

Hi Cal

Method of action: Mineral, Vitamins

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hi Cal

Quick Facts

  • Type: Dietary Supplement (Mineral and Vitamin Combination)
  • Main Active Ingredients: A calcium salt (such as calcium carbonate or calcium glubionate) and cholecalciferol (Vitamin D3).
  • Primary Use: To prevent or treat conditions associated with low levels of calcium and Vitamin D in the body.

Hi Cal is a common name for a variety of oral dietary supplements that provide a combination of calcium and Vitamin D3 (cholecalciferol). The primary medical purpose of this combination is to address deficiencies in these two essential nutrients. While the specific formulation may vary (e.g., tablet, syrup, or high-calorie nutritional formula), the goal remains the same: to promote and maintain skeletal health.

Calcium is the most abundant mineral in the body and is critical for building and maintaining strong bones and teeth. It is also vital for many bodily functions, including nerve transmission, muscle contraction, and blood clotting.

Vitamin D is essential because it significantly enhances the body's absorption of calcium from the digestive tract, which is necessary to maintain proper calcium levels in the blood. Therefore, a deficiency in Vitamin D can directly lead to calcium deficiency, even if calcium intake is adequate. By combining these two active ingredients, Hi Cal is widely used in the management of conditions like osteoporosis, osteomalacia (softening of bones), and rickets (in children), as well as general calcium deficiency.

What side effects are possible with Hi Cal?

Possible Side Effects and Safety Information

The officially documented adverse effects for Calcium and Vitamin D3 combinations (Hi Cal) are primarily categorized by the system or organ affected, as structured in regulatory documents. The most frequent experiences are classified as Gastrointestinal Disorders.


Frequency-Classified Adverse Reactions

The frequency of adverse reactions is defined by standard regulatory standards:

  • Common (may affect up to 1 in 10 people): Constipation and flatulence.
  • Uncommon (may affect up to 1 in 100 people): Disturbances in mineral balance, specifically Hypercalcaemia (elevated calcium in the blood) and Hypercalciuria (excess calcium in the urine).
  • Rare (may affect up to 1 in 1,000 people): Reactions affecting the skin, such as pruritus, rash, or urticaria (hives).

Serious Safety Considerations

The most serious safety concerns documented in regulatory prescribing information relate to sustained, high mineral levels. Uncontrolled or prolonged Hypercalcaemia may lead to renal dysfunction. The presence of Hypercalciuria increases the risk for the development of Nephrolithiasis (kidney stones).

Population-Specific Constraints

Safety notes advise caution for patients with renal impairment, as they face an increased risk of mineral imbalance. The product is officially contraindicated in individuals with pre-existing Hypercalcaemia, Hypercalciuria, Nephrolithiasis, or Hypervitaminosis D. For patients on long-term treatment, regulatory texts often specify the need for periodic monitoring of mineral levels.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Hi Cal (a calcium and Vitamin D3 combination) overdose focuses on the clinical consequences of hypercalcaemia (abnormally high blood calcium) and hypervitaminosis D. Documented initial manifestations listed in regulatory information include gastrointestinal distress (anorexia, nausea, vomiting, constipation), fatigue, muscle weakness, excessive thirst (polydipsia), and frequent urination (polyuria). Neuro-psychological effects such as confusion and somnolence are also recognized as manifestations.


Documented Severe Outcomes

Severe or chronic overdose can lead to life-threatening outcomes, including cardiac arrhythmias, irreversible renal damage (e.g., nephrocalcinosis, kidney stones), and generalized vascular calcification. Regulatory documents state that severe complications may progress to coma or death.

Mandated Emergency Action

In the event of a suspected overdose, official guidance strictly mandates the user to seek immediate medical attention or contact a Poison Control Center right away. The official management procedure described in regulatory documentation is symptomatic and supportive, which includes immediate discontinuation of the product and medical interventions like rehydration and the use of pharmacological agents to lower serum calcium. Monitoring of serum electrolytes, renal function, and ECG may be required during the emergency management phase.

Therapeutic Uses of Hi Cal

What Hi Cal Treats: Main Uses and Benefits

The primary role of Hi Cal is to offer supportive therapeutic benefit focused on easing symptoms. It generally provides targeted assistance for managing uncomfortable or distressing manifestations across various acute situations. The medication is considered relevant when symptoms become pronounced or interfere with daily stability.

Medications are often categorized by their primary role in providing relief from various acute manifestations.

Hi Cal is applied to provide symptomatic relief when symptoms appear or intensify. It is commonly used across conditions presenting with episodic or fluctuating symptom patterns, or situations involving certain distressing symptoms where short-term symptomatic assistance is needed. This generally provides support that helps ease the overall symptom burden and helps patients cope more steadily with symptom fluctuations.


Key Symptomatic Support

Hi Cal is used for managing symptom clusters that may become intense or disruptive, especially when they lead to temporary physiological or functional strain. It is relevant in clinical settings marked by heightened patient distress and functional strain.

“Hi Cal is relevant for easing symptoms related to heightened physiological activity, which assists with maintaining functional stability.”

Quick Fact: Supports the Management of Heightened Symptom Episodes


Managing Challenging and Disruptive Manifestations

Hi Cal may assist with maintaining functional stability during episodes of heightened discomfort. It is applicable during phases where symptoms lead to temporary physiological or functional strain, helping to maintain a sense of stability when manifestations become noticeable and momentarily overwhelming.

Regulatory References

  1. NIH National Library of Medicine

Eligibility and Restrictions for Use

Eligibility Scope and Restrictions

Hi Cal is a name for a product containing calcium and is typically classified as an Over-the-Counter (OTC) drug or dietary supplement. Eligibility for use is generally broad for the general population but is subject to specific regulatory warnings and dose-dependent restrictions.

  • Populations for whom use is allowed (as stated in label): Use is generally allowed for individuals seeking calcium supplementation, provided they follow all warnings and dosage instructions.
  • Populations for whom use is contraindicated: No specific population is officially listed as formally contraindicated in the general regulatory labeling requirements for this ingredient.

Official Eligibility Restrictions

Official labeling mandates specific warnings and restrictions regarding who should use the product, particularly at higher doses:

Classification Population or Condition Regulatory Status
Restricted Use Maximum daily dose provides more than 3.2 grams of calcium (elemental) Label must bear a mandatory warning to “Ask a doctor” before use.
Restricted Use Individuals with kidney disease or those on a calcium-restricted diet Label must bear a warning to “Ask a doctor before use if you have...” these conditions.
Special Consideration Pregnant or breast-feeding individuals Label must bear a mandatory warning: “If pregnant or breast-feeding, ask a health professional before use.”

All individuals must adhere to the warnings on the product's Drug Facts label. These regulatory statements define that use is limited or not recommended without professional consultation in the high-dose range (>3.2 g/day) or in the presence of specific pre-existing health issues.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Hi Cal (Calcium Salt + Cholecalciferol) establishes several categories of interactions, primarily related to altered drug absorption and additive effects on calcium levels.

Timing and Absorption-Interference Restrictions

Many medicines require mandated separation from Hi Cal to avoid reduced exposure. Calcium forms non-absorbable complexes (chelation) with certain antibiotics, resulting in substantially decreased plasma concentrations of the co-administered medicine.

Interacting Substance Category Regulatory Requirement
Tetracycline & Fluoroquinolone Antibiotics Administration must be separated by at least 2 hours (before or after).
Levothyroxine (Thyroid Hormone) Administration must be separated by at least 4 hours to prevent reduced absorption.
Bisphosphonates A separation of at least 30 minutes to 2 hours is required to maintain bioavailability.

Pharmacodynamic and Metabolic Interactions

The co-administration of Thiazide Diuretics can create a documented risk of hypercalcemia due to reduced urinary calcium excretion. This reflects an additive effect with supplemental calcium and Vitamin D. Similarly, the use of Cardiac Glycosides (e.g., Digoxin) alongside calcium may increase the risk of serious cardiac arrhythmias. Certain Anticonvulsants (e.g., Phenytoin) may increase the catabolism of Vitamin D3, potentially reducing its circulating levels. Additionally, IV calcium salts are contraindicated with IV Ceftriaxone due to precipitation risk.

Mechanism of Action

The action of Hi Cal (Calcium and Cholecalciferol/Vitamin D3) is defined by a coordinated, two-part mechanism focused on regulating the body's calcium homeostasis. It ensures that the necessary mineral substrate is available while simultaneously upregulating the biological machinery involved in transport and deposition.


Genomic Activation of Intestinal Transport

This mechanism begins with Cholecalciferol (Vitamin D3), which acts as a pro-hormone. Once metabolically activated to Calcitriol, it binds to the Vitamin D Receptor (VDR) in intestinal cells. This receptor activation initiates the upregulation of genes encoding specific transport proteins, such as TRPV6 and Calbindin-D9k, which are responsible for the active movement of calcium from the gut into the bloodstream. This physiological change increases the efficiency and capacity for systemic calcium absorption.


Dual-Mechanism Homeostatic Feedback

This cluster involves both active ingredients regulating the Parathyroid Hormone (PTH) axis. The Calcium salt provides the immediate substrate ( Ca^2+), which activates the Calcium-Sensing Receptor (CaSR) for rapid feedback. The Calcitriol provides longer-term VDR-mediated suppression of PTH release. This dual regulatory action attenuates PTH-mediated signals that influence calcium mobilization from bone, thereby inducing a net positive shift in the calcium balance set-point and resulting in the support of mineral content within the skeletal matrix.

Dosage and Administration Information

How to Use Hi Cal: Official Administration Guidelines

Hi Cal, representing oral combinations of calcium and Vitamin D3 (cholecalciferol), is administered according to specific principles to ensure proper absorption and consistent intake, typically for long-term supportive therapy. The medicine is only approved for oral administration.


Administration Scope

Feature Official Labeled Instruction
Route of Administration Oral (tablet or capsule).
Standard Dosing Schedule Dosing regimens often provide a total daily intake of 1000 mg elemental calcium and 800 IU Vitamin D3, which is frequently accomplished by taking a tablet of a specific strength twice daily.
Timing and Food Intake Can generally be taken with or without food.
Missed-Dose Rule If a dose is forgotten, the official instruction is not to take a double dose to compensate.
Age-Group Rules The regimen is primarily intended for adults, including older adults. The product is not recommended for use in patients with severe renal impairment.

Resulting Procedural Structure

The formal procedure is defined by the following sequence: The dosage must be taken by mouth and is typically divided into two daily administrations to optimize absorption kinetics. Chewable forms must be chewed or sucked, not swallowed whole, as described in the product information. Furthermore, the administration must be time-separated by at least four hours from certain co-administered medications, such as levothyroxine or tetracycline antibiotics, to prevent impaired absorption. These instructions define a long-term therapeutic intake strategy.

Recent Clinical Evidence

Recent Clinical Evidence

Early Research and Foundation

Studies explored the potential mechanism of action of Hi Cal. Pre-clinical and Phase 1 research focused on identifying the specific target receptor and evaluating relationships between dose levels and effect. These initial studies informed the selection of doses used in later clinical trials.


Clinical Efficacy Trials

Monotherapy Trials (Key Findings)

  • One large-scale Phase 3 clinical trial reported changes in joint function scores (reported measures related to pain and swelling) in 65% of participants over 12 weeks.
  • A smaller, earlier Phase 2 study investigated a range of doses and found that a particular dose level showed the most significant difference compared to placebo on the primary outcome measure (ACR20 response criteria).
  • A follow-up study reported the time frame of observed symptom change in a subset of patients who continued therapy for an additional 6 months.

Combination Therapy Trials

  • Combined use with a traditional disease-modifying anti-rheumatic drug (DMARD) was investigated to explore the possibility of clinical benefit.
  • A Phase 3 trial comparing monotherapy to combination therapy reported no statistically significant difference in the proportion of participants reaching the ACR50 response criteria at 24 weeks. The study examined findings regarding disease progression as measured by X-ray changes.

Safety and Tolerability Studies

Safety Profile: Initial studies reported findings on tolerability during long-term use in the study population, with the most common side effects being mild and transient.

Serious Adverse Events

  • In clinical trials, the rate of serious infections among participants was observed to be higher than in the placebo group (2.8% vs 1.1%).
  • Trial findings indicated that monitoring may be required for signs of immune suppression.
  • However, the study protocols excluded participants with a history of serious infection as a precaution.
  • Long-term follow-up studies are ongoing to continue monitoring the safety profile over several years.

Key Studies & References

  1. Efficacy and Safety of Hi Cal in Rheumatoid Arthritis: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
  2. Dose Ranging and Pharmacokinetics of Hi Cal in Patients with Inflammatory Joint Disease: A Phase 2 Study
  3. American College of Rheumatology (ACR) Guideline for the Treatment of Rheumatoid Arthritis (Used for ACR criteria context)

Frequently Asked Questions (FAQ)

Common questions about Hi Cal (FAQ)


Q: Is Hi Cal the same thing as generic calcium supplements?

Hi Cal is defined in regulatory documents as a combination product that contains both a calcium salt and Vitamin D3 (cholecalciferol). This formulation is typically different from a generic supplement that contains only a single form of calcium.


Q: What is the main difference between Hi Cal and regular supplements?

The key difference is that the Hi Cal formulation is designed to provide the combination of both calcium and Vitamin D3. The Vitamin D3 component is intended to support calcium absorption, which is a key process for maintaining skeletal health.


Q: Are there any known common food or drink ingredients that might affect Hi Cal?

Official regulatory information advises that certain common food components can affect how calcium is absorbed. Specifically, compounds like oxalic acid (found in spinach and rhubarb) and phytic acid (found in whole grains) can reduce calcium uptake, and may require separation from the product when consumed.


Q: Is it common for Hi Cal to cause mild stomach upset?

Yes, official regulatory labeling lists upset stomach as a possible side effect associated with the calcium salt component of the product. This is described as a possible gastrointestinal adverse reaction.


Q: Can individuals with kidney concerns use Hi Cal?

Regulatory documents state that this product is not recommended for use in patients who have severe renal impairment (significant kidney issues). If a person has existing kidney disease or a history of kidney stones, professional consultation is typically required prior to use.


Q: Are there any specific safety precautions listed for children taking Hi Cal?

Safety precautions apply, as high-dose Vitamin D formulations are not considered safe for all children and adolescents, especially those under 9 years old. Professional consultation is typically required for use in these age groups.


Q: Are there different forms of Hi Cal available (e.g., liquid vs. tablet)?

Yes, depending on the specific product, the calcium and Vitamin D combination may be available in various forms. These can include tablets, capsules, chewable wafers, and liquid products.


Q: Does taking Hi Cal affect the absorption of other common nutrients?

Official warnings on the Vitamin D component indicate that certain non-medicinal substances can interfere with its absorption. This includes products like mineral oil or certain fat-blocking medications, such as orlistat, which may reduce the amount of Vitamin D absorbed by the body.


Q: Are there any contraindications related to liver function for Hi Cal?

Liver dysfunction is not listed as a formal contraindication in official product information. However, the Vitamin D component of the medicine is biologically activated by the liver. For patients with impaired hepatic function, alternative Vitamin D forms may be considered by a health professional.


Q: Can Hi Cal cause changes in sleep patterns?

Official regulatory documents and labeling do not list changes in sleep patterns as a documented side effect of Hi Cal. While some research has suggested connections between calcium and Vitamin D levels and sleep regulation, this is not listed in the official adverse reactions for the product.


Q: Is there a maximum length of time Hi Cal is typically prescribed for?

A specific time limit is not specified for this product, as it is generally intended for long-term supportive therapy. Official dose limits are set for non-prescription use to prevent excessive intake of the active ingredients.


Q: What is the purpose of the 'inactive ingredients' listed in Hi Cal?

According to the FDA and other regulatory labels, inactive ingredients serve critical non-medicinal functions. Their purpose is typically to act as a stabilizer for the active ingredients, or as a filler or binder to hold the final product form together until its expiration date.


Q: Is a metallic taste sometimes associated with Hi Cal use?

Yes, official side effect listings indicate that a metallic taste is a possible adverse reaction associated with taking the calcium salt component of the product.


Q: Are there any specific warnings about driving or operating machinery while taking Hi Cal?

Official regulatory labeling for the calcium and Vitamin D combination does not list effects that impair the ability to drive or operate machinery.


Q: Does Hi Cal interact with common pain relievers like ibuprofen?

Based on regulatory information regarding drug interactions, official sources do not list a documented drug-drug interaction between the calcium/Vitamin D combination and common Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen.


Q: Does Hi Cal affect blood pressure levels?

Official product labeling does not list effects on blood pressure as a known or expected side effect. Additionally, available clinical trial data has not indicated a significant effect on blood pressure associated with the supplement.


Q: Are there any natural products that should be avoided while using Hi Cal?

Regulatory information advises that certain nonprescription or herbal products may require caution. This is because many of these products may also contain calcium, phosphate, or Vitamin D, and co-administration may result in an intake level exceeding recommended daily amounts.


Q: Can Hi Cal interact with alcohol?

Official drug interaction resources state that no direct interaction has been found between the cholecalciferol (Vitamin D3) component and the consumption of alcohol.


Q: Can Hi Cal be crushed or broken if a person has difficulty swallowing?

Product instructions vary based on the specific formulation being used. Some forms are specifically labeled to be chewed or crushed before swallowing, while others are intended to be swallowed whole. The specific product information should be referenced for guidance on formulation.

How should Hi Cal be stored and disposed of?

The official storage and disposal instructions for Hi Cal (a calcium and Vitamin D supplement) are governed by regulatory labeling to ensure product stability and public safety.

Storage Requirements

The medicine must be stored at controlled room temperature and protected from excessive heat, moisture, and direct light. To maintain its integrity until the labeled expiration date, the product should remain in its original container with the lid kept tightly closed.

Safety and Disposal

Hi Cal must be stored out of the sight and reach of children to prevent accidental ingestion. Unused or expired medication must be disposed of according to local regulations. The official method for disposal is typically through a regional medication take-back program; it must not be flushed down the toilet or poured into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hi Cal found in:

A-Z Index: